CD8A and neoplasm: Single immune cell counts using antibodies against the markers PD-1, CD3, CD8, CD4, CD20, CD45RO, CD138, CD163, FOXP3, and NK46p were determined within the tumor and the associated stroma for the Uppsala 06 cohort.